Myomo, Inc. (MYO) stock
MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.88−0.04 (-4.23%)
Close on Nov 18, 2026Market cap $34.85MP/E –Yield –
Myomo EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Myomo's EPS for the twelve months ending Jun 30, 2026 was -$0.34. For fiscal 2025 it was -$0.37. The highest annual figure on record is -$0.16 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.37 | – |
| FY2024 | Dec 31, 2024 | -$0.16 | – |
| FY2023 | Dec 31, 2023 | -$0.28 | – |
| FY2022 | Dec 31, 2022 | -$1.52 | – |
| FY2021 | Dec 31, 2021 | -$1.89 | – |
| FY2020 | Dec 31, 2020 | -$3.67 | – |
| FY2019 | Dec 31, 2019 | -$20.79 | – |
| FY2018 | Dec 31, 2018 | -$25.18 | – |
| FY2017 | Dec 31, 2017 | -$87.90 | – |
| FY2016 | Dec 31, 2016 | -$123.90 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.09 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.07 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.09 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.09 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.11 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.08 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.01 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.03 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.03 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.10 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.07 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.06 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.04 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.11 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.29 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.40 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.42 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.41 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.50 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.36 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.46 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.57 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.70 | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.12 | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.51 | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.81 | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.87 | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.50 | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.82 | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.49 | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.30 | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.30 | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.00 | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.30 | – |
| Q2 FY2017 | Jun 30, 2017 | -$100.50 | – |
| Q1 FY2017 | Mar 31, 2017 | -$46.50 | – |
| Q4 FY2016 | Dec 31, 2016 | -$37.64 | – |
| Q3 FY2016 | Sep 30, 2016 | -$32.70 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?